# Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors

> **NCT00389922** · PHASE1 · COMPLETED · sponsor: **University of California, Davis** · enrollment: 22 (actual)

## Conditions studied

- Unspecified Adult Solid Tumor, Protocol Specific

## Interventions

- **DRUG:** lapatinib ditosylate
- **DRUG:** vinorelbine ditartrate
- **GENETIC:** comparative genomic hybridization
- **GENETIC:** cytogenetic analysis
- **GENETIC:** gene expression analysis
- **GENETIC:** mutation analysis
- **GENETIC:** polymerase chain reaction
- **GENETIC:** polymorphism analysis
- **GENETIC:** proteomic profiling
- **GENETIC:** reverse transcriptase-polymerase chain reaction
- **OTHER:** immunohistochemistry staining method
- **OTHER:** laboratory biomarker analysis
- **DRUG:** lapatinib ditosylate
- **DRUG:** Vinorelbine ditartrate

## Key facts

- **NCT ID:** NCT00389922
- **Lead sponsor:** University of California, Davis
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2009-04
- **Final completion:** 2011-12
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2012-04-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00389922

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00389922, "Lapatinib and Vinorelbine in Treating Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT00389922. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*